Peri-procedural Management of Anticoagulation Therapy (cataract eye surgery, dental procedure and gastrointestinal endoscopy).
10.18501/arrhythmia.2016.008
- Author:
Joong Wha CHUNG
1
Author Information
1. Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Korea. chungjoongwha@gmail.com
- Publication Type:Review
- Keywords:
Anticoagulants;
Procedures;
Cataract;
Tooth Extraction;
Endoscopy
- MeSH:
Anticoagulants;
Atrial Fibrillation;
Cataract;
Endoscopy;
Endoscopy, Gastrointestinal;
Heart Valves;
Hemorrhage;
Heparin;
Humans;
Thromboembolism;
Tooth Extraction;
Venous Thromboembolism;
Warfarin
- From:International Journal of Arrhythmia
2016;17(1):51-55
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Anticoagulation therapy is widely used to prevent thromboembolism in patients with atrial fibrillation, venous thromboembolism, and mechanical heart valves. The temporary interruption of anticoagulants is common to reduce the bleeding risk during peri-procedures. Traditionally, warfarin was held for several days before procedures with heparin bridging therapy. However, recent data showed that stopping warfarin was not necessary before procedures with a low bleeding risk, such as a gastrointestinal endoscopy, cataract eye surgery, and dental procedures when the thromboembolic risk of the patient is moderate-to-high. This review article outlines the estimation of the thromboembolic and bleeding risk before procedures, and determines the timing of anticoagulant interruption.
